Randomized controlled trial of Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus-genotype 4 among Egyptian patients.

被引：0
|
作者：
Thakeb, FIA
Omar, MM
El Awady, MM
Isshak, SY
机构：
[1] Cairo Univ, Cairo, Egypt
[2] Theidor Bilharz Res Inst, Cairo, Egypt
[3] Acad Res & Sci, Cairo, Egypt
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
252
引用
收藏
页码：278A / 278A
页数：1
相关论文
共 50 条
  • [31] Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
    Sulkowski, Mark S.
    Bourliere, Marc
    Bronowicki, Jean-Pierre
    Asselah, Tarik
    Pawlotsky, Jean-Michel
    Shafran, Stephen D.
    Pol, Stanislas
    Mauss, Stefan
    Larrey, Dominique
    Datsenko, Yakov
    Stern, Jerry O.
    Kukolj, George
    Scherer, Joseph
    Nehmiz, Gerhard
    Steinmann, Gerhard G.
    Boecher, Wulf O.
    HEPATOLOGY, 2013, 57 (06) : 2155 - 2163
  • [32] Randomized controlled trial of nitazoxanide-peginterferon-ribavirin, nitazoxanide-peginterferon and peginterferon-ribavirin in the treatment of patients with chronic hepatitis C genotype 4
    Rossignol, J. F.
    Elfert, A.
    El-Gohary, Y.
    Keeffe, E. B.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S30 - S30
  • [33] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [34] Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 157 - 159
  • [35] Peginterferon alfa-2a in patients with chronic hepatitis C
    Zeuzem, S
    Feinman, SV
    Rasenack, J
    Heathcote, EJ
    Lai, MY
    Gane, E
    O'Grady, J
    Reichen, J
    Diago, M
    Lin, A
    Hoffman, J
    Brunda, MJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1666 - 1672
  • [36] PHOENIX: A Randomized Controlled Trial of Peginterferon alfa-2a/Ribavirin Prophylactic Treatment after Liver Transplant for Hepatitis C
    Bzowej, Natalie
    Nelson, David R.
    Terrault, Norah A.
    Everson, Gregory T.
    Teng, Lichen L.
    Prabhakar, Avinash
    Charlton, Michael R.
    LIVER TRANSPLANTATION, 2010, 16 (06) : S118 - S118
  • [37] A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
    Flisiak, Robert
    Shiffman, Mitchell
    Arenas, Juan
    Cheinquer, Hugo
    Nikitin, Igor
    Dong, Yuping
    Rena, Khurram
    Srinivasan, Subasree
    PLOS ONE, 2016, 11 (10):
  • [38] Interim analysis of the safety and efficacy of peginterferon alfa-2a plus ribavirin in chronic hepatitis C patients unable to tolerate or nonresponsive to treatment with peginterferon alfa-2b plus ribavirin
    Rustgi, VK
    Esposito, S
    Freilich, B
    Lopez-Talavera, JC
    Lentz, E
    Shiffman, ML
    HEPATOLOGY, 2005, 42 (04) : 692A - 692A
  • [39] Clinical and persistency outcomes in hepatitis C patients treated with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, T. I.
    Ye, X.
    Blumentals, W. A.
    Brixner, D. I.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S295 - S296
  • [40] Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
    Liu, Chun-Jen
    Chuang, Wan-Long
    Lee, Chuan-Mo
    Yu, Ming-Lung
    Lu, Sheng-Nan
    Wu, Shun-Sheng
    Liao, Li-Ying
    Chew, Chi-Ling
    Kuo, Hsing-Tao
    Chao, You-Chen
    Tung, Shui-Yi
    Yang, Sien-Sing
    Kao, Jia-Horng
    Liu, Chen-Hua
    Su, Wei-Wen
    Lin, Chih-Lin
    Jeng, Yung-Ming
    Chen, Pei-Jer
    Chen, Ding-Shinn
    GASTROENTEROLOGY, 2009, 136 (02) : 496 - 504
12345